These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38092739)

  • 1. Anti-VEGFR2 F(ab')
    Liu D; Song Y; Chen H; You Y; Zhu L; Zhang J; Xu X; Hu J; Huang X; Wu X; Xu X; Jiang S; Du Y
    Nat Commun; 2023 Dec; 14(1):8268. PubMed ID: 38092739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody Fragment F(ab')
    Li Q; Peterson N; Hanna RN; Kuszpit K; White J; Allen KL; Barnes A; Rickert KW; Shan L; Wu H; Dall'Acqua WF; Tsui P; Borrok MJ
    Mol Pharm; 2020 Feb; 17(2):507-516. PubMed ID: 31841002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody Fab' fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab')2 fragments.
    Wilbur DS; Stray JE; Hamlin DK; Curtis DK; Vessella RL
    Bioconjug Chem; 1994; 5(3):220-35. PubMed ID: 7918742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and activity of conjugate of monoclonal antibody HAb18 against hepatoma F(ab')(2) fragment and staphylococcal enterotoxin A.
    Yang LJ; Sui YF; Chen ZN
    World J Gastroenterol; 2001 Apr; 7(2):216-21. PubMed ID: 11819763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fuxin Granules ameliorate diabetic nephropathy in db/db mice through TGF-β1/Smad and VEGF/VEGFR2 signaling pathways.
    Zheng W; Qian C; Xu F; Cheng P; Yang C; Li X; Lu Y; Wang A
    Biomed Pharmacother; 2021 Sep; 141():111806. PubMed ID: 34246190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibitory effect of L-lysine on renal accumulation of 67Cu-labelled F(ab')2 fragments in mice.
    Rutherford RA; Smith A; Waibel R; Schubiger PA
    Int J Cancer; 1997 Jul; 72(3):522-9. PubMed ID: 9247299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idarubicin-145-2C11-F(ab')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allografts.
    Han WR; Murray-Segal LJ; Gershenzon A; Zhang JG; Hodder AN; Pietersz GA; Mottram PL
    Transpl Immunol; 1999 Dec; 7(4):207-13. PubMed ID: 10638833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization, and in vivo biodistribution properties of synthetically cross-linked multivalent antitumor antibody fragments.
    Schott ME; Frazier KA; Pollock DK; Verbanac KM
    Bioconjug Chem; 1993; 4(2):153-65. PubMed ID: 7873647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
    MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of unlabelled monoclonal antibodies on the biodistribution of 111In-labelled anti-prostate-specific acid phosphatase monoclonal antibodies in the mouse model.
    Peräalä-Heape M; Vihko P; Vihko R
    Anticancer Res; 1991; 11(3):1327-31. PubMed ID: 1888168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-linked monoclonal antibody fragment for improved tumor targeting.
    Stalteri MA; Mather SJ
    Bioconjug Chem; 1995; 6(2):179-86. PubMed ID: 7599261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
    Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
    Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
    J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
    Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
    J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody.
    Negri DR; Tosi E; Valota O; Ferrini S; Cambiaggi A; Sforzini S; Silvani A; Ruffini PA; Colnaghi MI; Canevari S
    Br J Cancer; 1995 Oct; 72(4):928-33. PubMed ID: 7547242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the in vitro and in vivo activities of IgG and F(ab')2 fragments of a mixture of three monoclonal anti-Her-2 antibodies.
    Spiridon CI; Guinn S; Vitetta ES
    Clin Cancer Res; 2004 May; 10(10):3542-51. PubMed ID: 15161714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
    Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
    Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal-cell carcinoma xenografts: relative effects of size and affinity.
    van Dijk J; Zegveld ST; Fleuren GJ; Warnaar SO
    Int J Cancer; 1991 Jul; 48(5):738-43. PubMed ID: 1830033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodination of murine anti-alpha-foetoprotein E.9 monoclonal antibody and its F(ab')2 fragment for the diagnosis of hepatocellular carcinoma.
    Beyers M; Aspinall S; Conradie JD; Fourie PJ
    Nuklearmedizin; 1988 Jun; 27(3):87-94. PubMed ID: 2457207
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.